ArtryaASX:AYA -1.33%30 FCF Margin % is -16,104.41% as of Dec. 2025. GuruFocus rates ASX:AYA with a GF Score™ of 30/100. The stock has 1 warning sign investors should review. Among 669 Healthcare Providers & Services companies, Artrya ranks worse than 100% on this metric.
FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Artrya's Free Cash Flow for the
six
months ended in Dec. 2025 was A$-10.95 Mil. Artrya's Revenue for the
six
months ended in Dec. 2025 was A$0.07 Mil. Therefore, Artrya's FCF Margin % for the quarter that ended in Dec. 2025 was -16,104.41%.
The historical rank and industry rank for Artrya's FCF Margin % or its related term are showing as below:
ASX:AYA'
s FCF Margin % Range Over the Past 10 Years
Min: -51907.14 Med: -51907.14 Max: -25757.83
Current: -25757.83
During the past 5 years, the highest FCF Margin % of Artrya was -25757.83%. The lowest was -51907.14%. And the median was -51907.14%.
ASX:AYA's FCF Margin % is ranked worse than 100% of 669
companies
in the Healthcare Providers & Services industry
Industry Median: 3.39
vs ASX:AYA: -25757.83
Artrya FCF Margin % Related Terms
Artrya FCF Margin % Historical Data
* Premium members only.
The historical data trend for Artrya's FCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ASX:AYA vs VEEV, BTSG, TEM: FCF Margin % Comparison
For the Health Information Services subindustry, Artrya's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Artrya FCF Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Artrya's FCF Margin % distribution charts can be found below:
* The bar in red indicates where Artrya's FCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Artrya (ASX:AYA) has a FCF Margin % of -16,104.41% as of Dec. 2025. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Artrya and its competitors. According to the industry distribution chart, Artrya ranks #669 out of 669 companies in the Healthcare Providers & Services industry.
Is Artrya's FCF Margin % too high?
Artrya's current FCF Margin % is -16,104.41%. Based on the distribution chart, Artrya ranks #669 out of 669 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Artrya has a GF Score™ of 30/100, reflecting its overall financial health beyond just this single metric.
How does Artrya's FCF Margin % compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, Artrya ranks #669 out of 669 companies for FCF Margin %. This places Artrya in the lower half of its industry. The industry median FCF Margin % is 3.39. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Healthcare Providers & Services company?
The median FCF Margin % among Healthcare Providers & Services companies is 3.39, based on 669 companies in the industry. Companies in the top quartile (top 25%) have a FCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Artrya and its competitors. For the Healthcare Providers & Services industry, the median FCF Margin % is 3.39 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Artrya's current FCF Margin % is -16,104.41%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Artrya stock overvalued right now?
Artrya (ASX:AYA) has a current FCF Margin % of -16,104.41%. The current FCF Margin % is -16,104.41%. Artrya's overall GF Score™ is 30/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Artrya (ASX:AYA), the current FCF Margin % is -16,104.41% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Artrya Ltd is a medical technology company. The company is engaged in the development and commercialization of Artrya Salix, its patented artificial intelligence platform that detects, diagnoses, and helps address coronary artery disease. It is managed based on a single segment, being the development of AI-driven CCTA image analysis technology.
30GF Score
Get the complete analysis for ASX:AYA
FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:AYA has been successfully added to your 
